|
業務類別
|
Biotechnology |
|
業務概覽
|
SL Science Holding Ltd is a biomedical company focused on the development of cellular and gene therapies. The company works on therapies using immune stem cells to target cancer and bovine-derived milk exosomes for tissue regeneration, with potential applications across medicine. Its proprietary technologies include Armed-T and Gamma Delta T cells, as well as exosome-based applications in skincare and cancer recovery. It develops cellular therapies within the broader biopharmaceutical and immuno-oncology sectors. |
| 公司地址
| 1412 Broadway, 21st Floor, Suite 21V, New York, NY, USA, 10018 |
| 電話號碼
| +1 646 257-5537 |
| 傳真號碼
| -- |
| 公司網頁
| |
| 員工數量
| 2 |
| Mr. Mingyu Michael Li |
Chief Executive Officer and Chairman of the Board |
-- |
08/04/2026 |
| Ms. Min Lydia Zhai |
Chief Financial Officer and Principal Accounting Officer |
-- |
08/04/2026 |
|
|
| Mr. Mingyu Michael Li |
Chief Executive Officer and Chairman of the Board |
08/04/2026 |
| Ms. Tianchen Cai |
Independent Director |
08/04/2026 |
| Dr. James Jiayuan Tong, PhD |
Independent Director |
08/04/2026 |
| Ms. Qian Hebe Xu |
Independent Director |
08/04/2026 |
|
|
|
|
